{
  "Q0": "BRCA1/BRCA2 genetic testing",
  "Q1": "Yes",
  "Q2": "No",
  "Q3": "No",
  "Q4": "No",
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "No",
  "Q8": "Yes",
  "Q8_description": "A more appropriate test would be a multigene panel testing for moderate to high-penetrance breast and/or epithelial ovarian cancer susceptibility genes, as per policy section D.",
  "Q9": "Yes",
  "Q9_additional": "No",
  "Q10": "No",
  "Q10_additional": "Risk Assessment",
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Yes",
  "Q14": "Yes",
  "Q14_additional": "81162",
  "Q15": "No",
  "Q16": "No",
  "Q17": "The policy requires the completion of an 'Aetna Breast and Ovarian Cancer Susceptibility Gene Testing Prior Authorization Form' along with the Laboratory's Test Requisition Form for precertification. Documentation of specific cancer diagnosis in the proband(s) and pertinent medical records may be required prior to authorization. A summary indicating how this testing will change the immediate medical care of the member must also be included with the Prior Authorization request."
}